Current Atherosclerosis Reports

, Volume 6, Issue 4, pp 261–266 | Cite as

Cardiovascular risk factors and Alzheimer’s disease

  • José A. Luchsinger
  • Richard Mayeux


Alzheimer’s disease is a devastating condition that is increasing in prevalence. No known prevention or cure exists for Alzheimer’s disease. Cardiovascular risk factors are prevalent and increase in the elderly, and there have been conflicting reports of associations between modifiable cardiovascular risk factors and Alzheimer’s disease. The mechanisms for these associations are uncertain, but they are likely to be the result of a combination of direct and cerebrovascular disease-related mechanisms. From this standpoint, diabetes and hyperinsulinemia seem to have the strongest evidence from laboratory, clinical, and epidemiologic studies. Studies have also indicated that hypertension, hyperlipidemia, hyperhomocysteinemia, and smoking are potentially important risk factors for Alzheimer’s disease.


Dementia Homocysteine Cardiovascular Risk Factor Vascular Dementia Hyperhomocysteinemia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Brookmeyer R, Gray S, Kawas C: Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998, 88:1337–1342.PubMedCrossRefGoogle Scholar
  2. 2.
    Harris MI, Flegal KM, Cowie CC, et al.: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988–1994. Diabetes Care 1998, 21:518–524.PubMedCrossRefGoogle Scholar
  3. 3.
    Vasan RS, Beiser A, Seshadri S, et al.: Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002, 287:1003–1010.PubMedCrossRefGoogle Scholar
  4. 4.
    Ritchie K, Lovestone S: The dementias [see comment]. Lancet 2002, 360:1759–1766.PubMedCrossRefGoogle Scholar
  5. 5.
    Kalaria RN: The role of cerebral ischemia in Alzheimer’s disease. Neurobiol Aging 2000, 21:321–330.PubMedCrossRefGoogle Scholar
  6. 6.
    Breteler MM: Vascular risk factors for Alzheimer’s disease: an epidemiologic perspective. Neurobiol Aging 2000, 21:153–160.PubMedCrossRefGoogle Scholar
  7. 7.
    Mungas D, Reed BR, Ellis WG, Jagust WJ: The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease. Arch Neurol 2001, 58:1243–1247.PubMedCrossRefGoogle Scholar
  8. 8.
    Amaral DG, Insausti R: The hyppocampal formation. In The Human Nervous System. Edited by Paxinos G. San Diego: Academic Press; 1990.Google Scholar
  9. 9.
    Sacco RL, Benjamin EJ, Broderick JP, et al.: American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors [see comment]. Stroke 1997, 28:1507–1517.PubMedGoogle Scholar
  10. 10.
    Honig LS, Tang MX, Albert S, et al.: Stroke and the risk of Alzheimer disease. Arch Neurol 2003, 60:1707–1712.PubMedCrossRefGoogle Scholar
  11. 11.
    Vermeer SE, Prins ND, den Heijer T, et al.: Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003, 348:1215–1222.PubMedCrossRefGoogle Scholar
  12. 12.
    Reaven GM, Laws A: Insulin Resistance: The Metabolic Syndrome X. Totowa, New Jersey: Humana Press; 1999.Google Scholar
  13. 13.
    Park CR: Cognitive effects of insulin in the central nervous system. Neurosci Biobehav Rev 2001, 25:311–323.PubMedCrossRefGoogle Scholar
  14. 14.
    Watson GS, Peskind ER, Asthana S, et al.: Insulin increases CSF A(beta)42 levels in normal older adults. Neurology 2003, 60:1899–1903.PubMedGoogle Scholar
  15. 15.
    Farris W, Mansourian S, Chang Y, et al.: Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci U S A 2003, 100:4162–4167.PubMedCrossRefGoogle Scholar
  16. 16.
    Razay G, Wilcock GK: Hyperinsulinaemia and Alzheimer’s disease. Age Ageing 1994, 23:396–399.PubMedCrossRefGoogle Scholar
  17. 17.
    Kuusisto J, Koivisto K, Mykkanen L, et al.: Association between features of the insulin resistance syndrome and Alzheimer’s disease independently of apolipoprotein E4 phenotype: cross sectional population based study. BMJ 1997, 315:1045–1049.PubMedGoogle Scholar
  18. 18.
    Stolk RP, Breteler MM, Ott A, et al.: Insulin and cognitive function in an elderly population. The Rotterdam Study. Diabetes Care 1997, 20:792–795.PubMedCrossRefGoogle Scholar
  19. 19.
    Sasaki N, Fukatsu R, Tsuzuki K, et al.: Advanced glycation end products in Alzheimer’s disease and other neurodegenerative diseases. Am J Pathol 1998, 153:1149–1155.PubMedGoogle Scholar
  20. 20.
    Ott A, Stolk RP, van Harskamp F, et al.: Diabetes mellitus and the risk of dementia. The Rotterdam Study. Neurology 1999, 53:1937–1942.PubMedGoogle Scholar
  21. 21.
    Leibson CL, Rocca WA, Hanson VA, et al.: Risk of dementia among persons with diabetes mellitus: a population- based cohort study. Am J Epidemiol 1997, 145:301–308.PubMedGoogle Scholar
  22. 22.
    Luchsinger JA, Tang MX, Stern Y, et al.: Diabetes mellitus and risk of Alzheimer’s disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 2001, 154:635–641.PubMedCrossRefGoogle Scholar
  23. 23.
    Peila R, Rodriguez BL, Launer LJ for the Honolulu-Asia Aging Study: Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging study. Diabetes 2002, 51:1256–1262.PubMedCrossRefGoogle Scholar
  24. 24.
    Stevens J, Cai J, Pamuk ER, et al.: The effect of age on the association between body-mass index and mortality [see comment]. N Engl J Med 1998, 338:1–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Nourhashemi F, Deschamps V, Larrieu S, et al.: Body mass index and incidence of dementia: The PAQUID study. Neurology 2003, 60:117–119.PubMedCrossRefGoogle Scholar
  26. 26.
    Kivipelto M, Laakso MP, Tuomilehto J, et al.: Hypertension and hypercholesterolaemia as risk factors for Alzheimer’s disease: potential for pharmacological intervention. CNS Drugs 2002, 16:435–444.PubMedCrossRefGoogle Scholar
  27. 27.
    Skoog I, Lernfelt B, Landahl S, et al.: 15-year longitudinal study of blood pressure and dementia. Lancet 1996, 347:1141–1145.PubMedCrossRefGoogle Scholar
  28. 28.
    Posner HB, Tang MX, Luchsinger J, et al.: The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology 2002, 58:1175–1181.PubMedGoogle Scholar
  29. 29.
    in’t Veld BA, Ruitenberg A, Hofman A, et al.: Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging 2001, 22:407–412.CrossRefGoogle Scholar
  30. 30.
    SHEP Investigators: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991, 265:3255–3264.CrossRefGoogle Scholar
  31. 31.
    Applegate WB, Pressel S, Wittes J, et al.: Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. Arch Intern Med 1994, 154:2154–2160.PubMedCrossRefGoogle Scholar
  32. 32.
    Prince MJ, Bird AS, Blizard RA, Mann AH: Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council’s trial of hypertension in older adults. BMJ 1996, 312:801–805.PubMedGoogle Scholar
  33. 33.
    Kivipelto M, Helkala EL, Laakso MP, et al.: Midlife vascular risk factors and Alzheimer’s disease in later life: longitudinal, population based study. BMJ 2001, 322:1447–1451.PubMedCrossRefGoogle Scholar
  34. 34.
    Jick H, Zornberg GL, Jick SS, et al.: Statins and the risk of dementia. Lancet 2000, 356:1627–1631.PubMedCrossRefGoogle Scholar
  35. 35.
    Moroney JT, Tang MX, Berglund L, et al.: Low-density lipoprotein cholesterol and the risk of dementia with stroke. JAMA 1999, 282:254–260.PubMedCrossRefGoogle Scholar
  36. 36.
    Shepherd J, Blauw GJ, Murphy MB, et al.: Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial [see comment]. Lancet 2002, 360:1623–1630.PubMedCrossRefGoogle Scholar
  37. 37.
    Seshadri S, Beiser A, Selhub J, et al.: Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med 2002, 346:476–483.PubMedCrossRefGoogle Scholar
  38. 38.
    Luchsinger JA, Tang MX, Shea S, et al.: Plasma homocysteine levels and risk of Alzheimer’s disease. Neurology 2004, In press.Google Scholar
  39. 39.
    Breteler MM: Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study. Ann N Y Acad Sci 2000, 903:457–465.PubMedCrossRefGoogle Scholar
  40. 40.
    Merchant C, Tang MX, Albert S, et al.: The influence of smoking on the risk of Alzheimer’s disease [see comment]. Neurology 1999, 52:1408–1412.PubMedGoogle Scholar
  41. 41.
    Belleville J: The French paradox: possible involvement of ethanol in the protective effect against cardiovascular diseases. Nutrition 2002, 18:173–177.PubMedCrossRefGoogle Scholar
  42. 42.
    Mukamal KJ, Kuller LH, Fitzpatrick AL, et al.: Prospective study of alcohol consumption and risk of dementia in older adults. JAMA 2003, 289:1405–1413.PubMedCrossRefGoogle Scholar
  43. 43.
    Ruitenberg A, van Swieten JC, Witteman JC, et al.: Alcohol consumption and risk of dementia: the Rotterdam Study. Lancet 2002, 359:281–286.PubMedCrossRefGoogle Scholar
  44. 44.
    Truelsen T, Thudium D, Gronbaek M, for the Copenhagen City Heart Study: Amount and type of alcohol and risk of dementia: the Copenhagen City Heart Study [see comment]. Neurology 2002, 59:1313–1319.PubMedGoogle Scholar
  45. 45.
    Luchsinger JA: Alcohol intake and risk of Alzheimer’s disease. J Am Geriatr Soc 2004, In press.Google Scholar
  46. 46.
    Orgogozo JM, Dartigues JF, Lafont S, et al.: Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev Neurol (Paris) 1997, 153:185–192.Google Scholar
  47. 47.
    Linday J, Laurin D, Verreault R: Risk factors for Alzheimer’s disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 2002, 156:445–453.CrossRefGoogle Scholar
  48. 48.
    Kalmijn S, Foley D, White L, et al.: Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol 2000, 20:2255–2260.PubMedGoogle Scholar

Copyright information

© Current Science Inc 2004

Authors and Affiliations

  • José A. Luchsinger
    • 1
  • Richard Mayeux
    • 1
  1. 1.Taub Institute for Research of Alzheimer’s Disease and the Aging BrainColumbia UniversityNew YorkUSA

Personalised recommendations